LEMAITRE VASCULAR INCLMATEarnings & Financial Report
LeMaitre Vascular is an American medical device company established in 1986 by vascular surgeon George D. LeMaitre, and based in Burlington, Massachusetts, which provides devices, implants and human tissue cryopreservation services used by surgeons in the treatment of vascular conditions, particularly peripheral vascular disease. As of 2022, LeMaitre Vascular sells directly to hospitals in 25 countries and through distributors in more than 70 countries throughout North America, Europe and Asi...
LMAT Q3 2025 Key Financial Metrics
Revenue
$61.0M
Gross Profit
$46.0M
Operating Profit
$20.3M
Net Profit
$17.4M
Gross Margin
75.3%
Operating Margin
33.3%
Net Margin
28.4%
YoY Growth
11.4%
EPS
$0.75
Financial Flow
LEMAITRE VASCULAR INC Q3 2025 Financial Summary
LEMAITRE VASCULAR INC reported revenue of $61.0M for Q3 2025, with a net profit of $17.4M (28.4% margin). Cost of goods sold was $15.1M, operating expenses totaled $25.6M.
Key Financial Metrics
| Total Revenue | $61.0M |
|---|---|
| Net Profit | $17.4M |
| Gross Margin | 75.3% |
| Operating Margin | 33.3% |
| Report Period | Q3 2025 |
LEMAITRE VASCULAR INC Annual Revenue by Year
LEMAITRE VASCULAR INC annual revenue history includes year-by-year totals (for example, 2024 revenue was $219.9M).
| Year | Annual Revenue |
|---|---|
| 2024 | $219.9M |
| 2023 | $193.5M |
| 2022 | $161.7M |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $48.9M | $53.5M | $55.8M | $54.8M | $55.7M | $59.9M | $64.2M | $61.0M |
| YoY Growth | 19.4% | 13.6% | 11.4% | 15.6% | 14.0% | 12.0% | 15.0% | 11.4% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $346.8M | $354.0M | $363.1M | $377.0M | $551.8M | $556.0M | $577.6M | $598.1M |
| Liabilities | $48.9M | $45.5M | $43.5M | $46.0M | $214.5M | $208.4M | $214.9M | $219.1M |
| Equity | $297.9M | $308.5M | $319.5M | $331.1M | $337.3M | $347.6M | $362.7M | $378.9M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $10.7M | $5.1M | $9.6M | $14.2M | $15.2M | $9.0M | $20.3M | $28.8M |